Australia To Streamline Drug Reimbursement Listing Processes From July
Executive Summary
Pharmaceutical companies in Australia can look forward to more streamlined processes for the submission and evaluation of new drugs for listing on the Pharmaceutical Benefits Scheme from July.
You may also be interested in...
Australia Trials ‘More Transparent’ PBS Listing Procedure
Stakeholders have been asked to test-run a new approach to preparing Public Summary Documents for medicines submitted for reimbursement in Australia.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.